Pregnancy and Breast Cancer

Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Recently, I attended two conferences about breast cancer, and both covered the special issue related to Pregnancy and Breast cancer. I think we are covering this issue more …

Timing of Postmastectomy Radiotherapy Following Adjuvant Chemotherapy for High-Risk Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Clinical Trial. Chen, Si-Ye eta al.

Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. How Long can you wait for Radiation after Surgery? Radiation treatment has remained an essential treatment particularly for those individuals who are at higher risk of breast cancer …

Approach for Early Stage HER 2 Neu Positive Breast Cancer

Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Dr. Adrienne Waks, breast oncologist at the Dana Farber Cancer Institute, recently presented at the 21st Annual International Future in Breast Cancer East (July 2022). She discussed the …

Long-term Outcomes of Adjuvant Denosumab in Breast Cancer: Fracture reduction and Survival of 3,425 patients in the randomized, double blind, placebo controlled ABCSG-18 trial.

Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Long-term use of Aromatase Inhibitors (AI) for endocrine blockade for postmenopausal women with hormone receptor positive breast cancer has been a well-established treatment for several decades in the …

Phase I Clinical Trial Enrollment Q&A with NEXT Oncology Physicians

Cancer patients and their caregivers often have questions when exploring treatment options, especially when it comes to early-stage clinical trials. The physicians and clinical investigators at NEXT Oncology have pulled together a list of frequently asked questions. In this blog, they answer the questions in a succinct manner, but encourage patients to have more in-depth conversations with their physicians when …

New Drug that works on all forms of Breast cancer

UPDATE – As of August 22, 2022 – The FDA has approved the use of Trastuzumab Deruxtecan for patients with low expressing HER2 Neu positive breast cancer survivors with recurrent, metastatic disease. It was previously only approved for patients with HER 2 Neu over/ High expressing (HER 2 Neu 3+ or FISH positive for HER 2 Neu) breast cancers. Due to …